The Ebola Pandemic 2026 market asks a narrow, source-specific question: will the World Health Organization explicitly call an Ebola outbreak a "pandemic" in an official communication before the year ends? It trades across roughly $571K in combined Kalshi and Polymarket volume as a binary Yes/No contract. The bar is high by design, and a PHEIC declaration alone does not satisfy it. The live board above shows the current cross-platform prices; the market resolves December 31, 2026.
The Ebola Pandemic 2026 market is one of the cleaner binary public-health contracts on the board because its resolution language leaves little room for interpretation. It does not ask whether an Ebola outbreak happens, whether cases cross a threshold, or whether the WHO declares an emergency. It asks one thing: does the WHO, in an official public communication, explicitly characterize Ebola or an Ebola outbreak as a "pandemic" before the year closes. That single-word standard is what separates this contract from broader outbreak markets, and it is why the contract trades where it does.
Ebola virus disease is a severe, often fatal illness that spreads through direct contact with bodily fluids rather than through the air. Historically, outbreaks have been geographically concentrated, most often in Central and West Africa, and have been contained through case isolation, contact tracing, safe burials, and vaccination campaigns. The 2014 to 2016 West Africa outbreak was the largest on record and remains the reference point for how severe an Ebola event can become, yet even that outbreak was never officially labeled a pandemic by the WHO.
That history matters for this market. The word "pandemic" implies sustained, worldwide human-to-human transmission across multiple regions. Ebola's transmission profile, requiring close physical contact, makes the kind of broad global spread the term describes far harder to reach than for a respiratory pathogen. The contract is structured to pay Yes only when the WHO itself reaches for that specific word, which is a deliberate, public, and rare designation.
The market is cross-platform, with contracts live on both Kalshi and Polymarket. That gives readers two independent order books pricing the same WHO-declaration question, and the live board above tracks where each platform sits and how wide the spread between them runs. Combined volume sits near $571K, enough to make the contract a meaningful read on how traders weigh a low-probability, well-defined event.
Resolution turns entirely on WHO language, and the contract is explicit about what counts. A qualifying event is an official WHO statement, report, press briefing, or publication that clearly describes Ebola, any Ebola strain, or any Ebola outbreak as a "pandemic." The communication has to be official and public, and the characterization has to be explicit rather than implied. Reporting from credible outlets that documents such a WHO characterization can also serve as a resolution input, with official WHO communications as the primary source of truth.
The most important distinction in the rules is the line drawn around a Public Health Emergency of International Concern, or PHEIC. The WHO has declared a PHEIC for Ebola before, and a PHEIC is a serious step under the International Health Regulations. But under this contract, a PHEIC by itself does not resolve the market Yes. The WHO would have to go further and actually describe the situation as a pandemic. That gap between "emergency" and "pandemic" is the entire question the market is pricing.
The market resolves on December 31, 2026, at 11:59 PM ET. It resolves Yes if, at any point between market creation and that deadline, the WHO explicitly characterizes Ebola or an Ebola outbreak as a pandemic in an official public communication. If no such characterization occurs by the deadline, the contract resolves No. Official WHO communications are the primary resolution source, with a consensus of credible reporting available as a secondary check.
For the broader version of this question across any disease, see the Pandemic in 2026 odds, which tracks whether the WHO declares any pandemic this year. The measles cases 2026 odds cover a different outbreak threshold in the United States and round out the public-health board. Browse the full tech prediction markets hub for related biotech and outbreak contracts, and see more from the Genius Staff analysis desk on how these markets price low-probability events.
Resolves Yes if the World Health Organization explicitly characterizes Ebola virus disease, any Ebola strain, or any Ebola outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. A qualifying characterization includes official WHO statements, reports, press briefings, or publications that clearly use the word pandemic. A Public Health Emergency of International Concern (PHEIC) alone does not qualify unless it is also described as a pandemic. Otherwise the market resolves No. The primary resolution source is official WHO communications, with a consensus of credible reporting available as a secondary check.
The market trades as a binary Yes/No contract across Kalshi and Polymarket with roughly $571K in combined volume. The live board above shows the current cross-platform prices and the spread between the two platforms.
It resolves on December 31, 2026, at 11:59 PM ET. It resolves Yes if the WHO explicitly characterizes Ebola or an Ebola outbreak as a pandemic in an official public communication before that deadline, and No otherwise.
The contract is live on both Kalshi and Polymarket, giving two independent order books pricing the same WHO-declaration question. The live board above compares both platforms side by side.
No. A Public Health Emergency of International Concern alone does not satisfy the resolution bar. The WHO would have to explicitly use the word pandemic in an official communication for the market to resolve Yes.
Watch for official WHO statements, briefings, or publications, since WHO language is the only direct catalyst. Outbreak scale, cross-border cases, and any escalation toward pandemic framing ahead of the December 31, 2026 deadline are the signals most likely to move the price.